2026 Drug Cost Guide: Keytruda, Wegovy, Mounjaro, Zepbound, Opdivo & Imfinzi Prices

Updated U.S. drug cost data (Keytruda, Wegovy, Mounjaro, Zepbound) — Insurance, savings & 2026 trends.

Showing 7 - 12 of 38 drug pricing articles
Donanemab Cost in 2026: Alzheimer’s Drug Price, Medicare Coverage & Patient Assistance Options - 2026 Drug Cost Analysis

Donanemab Cost in 2026: Alzheimer’s Drug Price, Medicare Coverage & Patient Assistance Options

59 views

Donanemab (Kisunla), Eli Lilly’s Alzheimer’s therapy, is priced around $32,000 per year in 2024–2025 and may rise slightly by 2026. This guide covers the latest projected prices, Medicare and insurance coverage, out-of-pocket estimates, and patient assistance programs available in the U.S. Compare Donanemab vs Leqembi costs, understand CMS registry requirements, and find financial aid options for Alzheimer’s patients.

How Much Does Leqembi Really Cost in 2026? A Complete Alzheimer’s Drug Price & Medicare Guide - 2026 Drug Cost Analysis

How Much Does Leqembi Really Cost in 2026? A Complete Alzheimer’s Drug Price & Medicare Guide

49 views

As Alzheimer’s treatments evolve, Leqembi (lecanemab) stands out as a breakthrough medication—but it comes with a high price tag. In 2026, costs vary depending on insurance coverage, infusion center fees, and Medicare approval. This updated guide reveals current U.S. Leqembi prices, coverage rules, and ways to reduce out-of-pocket expenses through assistance programs and manufacturer discounts.

Leqembi Cost in the US 2026: Alzheimer’s Drug Price, Insurance Coverage & Latest Medicare Data - 2026 Drug Cost Analysis

Leqembi Cost in the US 2026: Alzheimer’s Drug Price, Insurance Coverage & Latest Medicare Data

67 views

Leqembi (lecanemab) is the first FDA-approved Alzheimer’s treatment that directly targets amyloid-beta buildup — but how much does it really cost in 2026? In this updated U.S. guide, we break down the Leqembi cost per month and per year, analyze insurance and Medicare coverage, and compare it to similar Alzheimer’s drugs like Donanemab. We’ll also explore the latest 2025–2026 clinical data, real-world effectiveness, and the newest coverage decisions from Medicare Part B and private insurers. Whether you’re a caregiver, patient, or health professional, this complete Leqembi price analysis helps you understand what you’ll actually pay — and how to save on treatment costs in 2026.

How Much Does Wegovy Cost Per Month in 2026? Updated U.S. Price Guide & Savings Tips - 2026 Drug Cost Analysis

How Much Does Wegovy Cost Per Month in 2026? Updated U.S. Price Guide & Savings Tips

93 views

Wondering how much Wegovy really costs in 2026? This updated U.S. price guide breaks down the average monthly cost of Wegovy with and without insurance, pharmacy price differences, and the best ways to save through coupons, savings cards, and discount programs.

Ozempic Cost in the US 2026: Insurance Coverage, Monthly Price & Cheapest Pharmacies - 2026 Drug Cost Analysis

Ozempic Cost in the US 2026: Insurance Coverage, Monthly Price & Cheapest Pharmacies

35 views

Ozempic continues to be one of the most in-demand prescription drugs in the United States in 2026, especially among adults managing Type 2 diabetes and those seeking effective weight loss solutions. With prices continuing to rise and insurance coverage remaining complex, understanding the real monthly cost of Ozempic in 2026 can help Americans make smarter financial and health decisions. According to the latest 2026 U.S. pharmacy data, the average out-of-pocket cost for Ozempic without insurance is between $935 and $1,050 per month, depending on the dose and the pharmacy. However, patients with private insurance or Medicare Part D can pay as little as $25 to $100 per month through copay savings or manufacturer assistance programs. Below, you’ll find updated 2026 price comparisons, the best discount programs, and key pharmacy links offering the lowest Ozempic prices in the U.S.

Keytruda Cost in 2026: What You’ll Actually Pay (Latest U.S. Data & Savings Tips) - 2026 Drug Cost Analysis

Keytruda Cost in 2026: What You’ll Actually Pay (Latest U.S. Data & Savings Tips)

37 views

In 2026, the real cost of Keytruda (pembrolizumab) continues to rise across the U.S., with list prices now reaching $11,564 per 200 mg dose or $23,590 for the 400 mg / 6-week schedule. While insurance coverage, assistance programs, and Medicare options can significantly reduce out-of-pocket costs, many American patients still face bills ranging from $1,200 to $10,000 per month, depending on their plan. This article breaks down updated Keytruda pricing data for 2026, compares infusion costs by hospital and pharmacy, explains copay assistance options, and provides the latest policy updates about potential government price negotiations. You’ll also find detailed FAQs addressing what patients in the U.S. are actually paying, how insurance affects coverage, and where to find verified cost-saving programs. Read on to discover the latest Keytruda prices, insurance breakdowns, and patient support options available in 2026.

Drug Price FAQs: Keytruda, Wegovy, Mounjaro & More

The average cost of Keytruda without insurance in 2026 is around $10,000 to $13,000 per dose. With insurance, out-of-pocket expenses can be as low as $100 depending on the coverage.

Experts expect Zepbound’s price to drop by 10–15% in 2026 as competition and insurance coverage expand. Savings cards and manufacturer programs are also expected to continue.

Wegovy costs between $25 and $150 per month with most insurance plans in the U.S. Without insurance, the price is around $1,350 monthly.

Top Drug Comparisons 2026: Keytruda, Mounjaro, Wegovy & Zepbound

Keytruda vs Opdivo

Compare the 2026 cost, effectiveness, and insurance coverage of both cancer treatments.

Compare Now

Wegovy vs Zepbound

Find out which weight-loss drug offers the best value and results in 2026.

Read Comparison

Mounjaro Savings 2026

Learn how to get the best savings and discounts for Mounjaro through insurance and cards.

See Savings